nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—trigeminal nucleus—multiple sclerosis	0.0613	0.242	CbGeAlD
Zuclopenthixol—HTR2A—trigeminal nerve—multiple sclerosis	0.0161	0.0635	CbGeAlD
Zuclopenthixol—DRD1—nerve—multiple sclerosis	0.0151	0.0595	CbGeAlD
Zuclopenthixol—HTR2A—pons—multiple sclerosis	0.0113	0.0447	CbGeAlD
Zuclopenthixol—DRD2—nerve—multiple sclerosis	0.00891	0.0352	CbGeAlD
Zuclopenthixol—ADRA2A—peripheral nervous system—multiple sclerosis	0.00887	0.035	CbGeAlD
Zuclopenthixol—HTR2A—pineal body—multiple sclerosis	0.00809	0.0319	CbGeAlD
Zuclopenthixol—HTR2A—peripheral nervous system—multiple sclerosis	0.00754	0.0297	CbGeAlD
Zuclopenthixol—DRD1—brainstem—multiple sclerosis	0.00647	0.0255	CbGeAlD
Zuclopenthixol—HTR2A—nerve—multiple sclerosis	0.00588	0.0232	CbGeAlD
Zuclopenthixol—HTR6—nervous system—multiple sclerosis	0.00456	0.018	CbGeAlD
Zuclopenthixol—DRD5—nervous system—multiple sclerosis	0.00444	0.0175	CbGeAlD
Zuclopenthixol—HTR6—central nervous system—multiple sclerosis	0.00439	0.0173	CbGeAlD
Zuclopenthixol—DRD5—central nervous system—multiple sclerosis	0.00427	0.0169	CbGeAlD
Zuclopenthixol—DRD1—midbrain—multiple sclerosis	0.00413	0.0163	CbGeAlD
Zuclopenthixol—ADRA1A—brainstem—multiple sclerosis	0.0039	0.0154	CbGeAlD
Zuclopenthixol—DRD2—brainstem—multiple sclerosis	0.00383	0.0151	CbGeAlD
Zuclopenthixol—DRD2—retina—multiple sclerosis	0.00369	0.0146	CbGeAlD
Zuclopenthixol—HTR6—brain—multiple sclerosis	0.00349	0.0138	CbGeAlD
Zuclopenthixol—DRD5—brain—multiple sclerosis	0.00339	0.0134	CbGeAlD
Zuclopenthixol—DRD1—nervous system—multiple sclerosis	0.00339	0.0134	CbGeAlD
Zuclopenthixol—DRD1—central nervous system—multiple sclerosis	0.00327	0.0129	CbGeAlD
Zuclopenthixol—DRD1—brain—multiple sclerosis	0.00259	0.0102	CbGeAlD
Zuclopenthixol—HTR2A—brainstem—multiple sclerosis	0.00252	0.00995	CbGeAlD
Zuclopenthixol—DRD2—midbrain—multiple sclerosis	0.00244	0.00962	CbGeAlD
Zuclopenthixol—HTR2A—retina—multiple sclerosis	0.00243	0.0096	CbGeAlD
Zuclopenthixol—CYP2D6—brainstem—multiple sclerosis	0.0023	0.00907	CbGeAlD
Zuclopenthixol—ADRA2A—medulla oblongata—multiple sclerosis	0.00207	0.00816	CbGeAlD
Zuclopenthixol—ADRA1A—nervous system—multiple sclerosis	0.00204	0.00807	CbGeAlD
Zuclopenthixol—DRD2—nervous system—multiple sclerosis	0.002	0.00791	CbGeAlD
Zuclopenthixol—ADRA1A—central nervous system—multiple sclerosis	0.00197	0.00777	CbGeAlD
Zuclopenthixol—DRD2—central nervous system—multiple sclerosis	0.00193	0.00761	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—multiple sclerosis	0.00192	0.00759	CbGeAlD
Zuclopenthixol—ADRA2A—midbrain—multiple sclerosis	0.00189	0.00746	CbGeAlD
Zuclopenthixol—DRD2—cerebellum—multiple sclerosis	0.00189	0.00744	CbGeAlD
Zuclopenthixol—ADRA2A—spinal cord—multiple sclerosis	0.00185	0.00728	CbGeAlD
Zuclopenthixol—HTR2A—medulla oblongata—multiple sclerosis	0.00176	0.00694	CbGeAlD
Zuclopenthixol—HTR2A—midbrain—multiple sclerosis	0.00161	0.00634	CbGeAlD
Zuclopenthixol—HRH1—nervous system—multiple sclerosis	0.00158	0.00624	CbGeAlD
Zuclopenthixol—HTR2A—spinal cord—multiple sclerosis	0.00157	0.00619	CbGeAlD
Zuclopenthixol—ADRA1A—brain—multiple sclerosis	0.00156	0.00617	CbGeAlD
Zuclopenthixol—ADRA2A—nervous system—multiple sclerosis	0.00155	0.00613	CbGeAlD
Zuclopenthixol—DRD2—brain—multiple sclerosis	0.00153	0.00604	CbGeAlD
Zuclopenthixol—HRH1—central nervous system—multiple sclerosis	0.00152	0.00601	CbGeAlD
Zuclopenthixol—ADRA2A—central nervous system—multiple sclerosis	0.0015	0.00591	CbGeAlD
Zuclopenthixol—ADRA2A—cerebellum—multiple sclerosis	0.00146	0.00577	CbGeAlD
Zuclopenthixol—HTR2A—nervous system—multiple sclerosis	0.00132	0.00522	CbGeAlD
Zuclopenthixol—HTR2A—central nervous system—multiple sclerosis	0.00127	0.00502	CbGeAlD
Zuclopenthixol—HTR2A—cerebellum—multiple sclerosis	0.00124	0.00491	CbGeAlD
Zuclopenthixol—HRH1—brain—multiple sclerosis	0.00121	0.00477	CbGeAlD
Zuclopenthixol—CYP2D6—nervous system—multiple sclerosis	0.0012	0.00475	CbGeAlD
Zuclopenthixol—ADRA2A—brain—multiple sclerosis	0.00119	0.00469	CbGeAlD
Zuclopenthixol—CYP2D6—central nervous system—multiple sclerosis	0.00116	0.00457	CbGeAlD
Zuclopenthixol—CYP2D6—cerebellum—multiple sclerosis	0.00113	0.00447	CbGeAlD
Zuclopenthixol—HTR2A—brain—multiple sclerosis	0.00101	0.00399	CbGeAlD
Zuclopenthixol—CYP2D6—brain—multiple sclerosis	0.000921	0.00363	CbGeAlD
Zuclopenthixol—Dermatitis—Azathioprine—multiple sclerosis	0.000619	0.00108	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000619	0.00108	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000619	0.00108	CcSEcCtD
Zuclopenthixol—Discomfort—Triamcinolone—multiple sclerosis	0.000618	0.00108	CcSEcCtD
Zuclopenthixol—Discomfort—Methylprednisolone—multiple sclerosis	0.000617	0.00108	CcSEcCtD
Zuclopenthixol—Headache—Azathioprine—multiple sclerosis	0.000616	0.00108	CcSEcCtD
Zuclopenthixol—Dry mouth—Triamcinolone—multiple sclerosis	0.000612	0.00107	CcSEcCtD
Zuclopenthixol—Angiopathy—Prednisone—multiple sclerosis	0.000605	0.00106	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—multiple sclerosis	0.000603	0.00106	CcSEcCtD
Zuclopenthixol—Malaise—Betamethasone—multiple sclerosis	0.000601	0.00105	CcSEcCtD
Zuclopenthixol—Malaise—Dexamethasone—multiple sclerosis	0.000601	0.00105	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.0006	0.00105	CcSEcCtD
Zuclopenthixol—Vertigo—Betamethasone—multiple sclerosis	0.000599	0.00105	CcSEcCtD
Zuclopenthixol—Vertigo—Dexamethasone—multiple sclerosis	0.000599	0.00105	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000598	0.00105	CcSEcCtD
Zuclopenthixol—Syncope—Dexamethasone—multiple sclerosis	0.000598	0.00105	CcSEcCtD
Zuclopenthixol—Syncope—Betamethasone—multiple sclerosis	0.000598	0.00105	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—multiple sclerosis	0.000596	0.00104	CcSEcCtD
Zuclopenthixol—Sweating—Methotrexate—multiple sclerosis	0.000595	0.00104	CcSEcCtD
Zuclopenthixol—Shock—Triamcinolone—multiple sclerosis	0.00059	0.00103	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisolone—multiple sclerosis	0.00059	0.00103	CcSEcCtD
Zuclopenthixol—Shock—Methylprednisolone—multiple sclerosis	0.000589	0.00103	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000587	0.00103	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000587	0.00103	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000586	0.00103	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Betamethasone—multiple sclerosis	0.000586	0.00103	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000586	0.00103	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisolone—multiple sclerosis	0.000586	0.00103	CcSEcCtD
Zuclopenthixol—Tachycardia—Triamcinolone—multiple sclerosis	0.000585	0.00103	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—multiple sclerosis	0.000584	0.00102	CcSEcCtD
Zuclopenthixol—Nausea—Azathioprine—multiple sclerosis	0.000584	0.00102	CcSEcCtD
Zuclopenthixol—Tachycardia—Methylprednisolone—multiple sclerosis	0.000584	0.00102	CcSEcCtD
Zuclopenthixol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000581	0.00102	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—multiple sclerosis	0.000581	0.00102	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—multiple sclerosis	0.000581	0.00102	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00058	0.00102	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Methotrexate—multiple sclerosis	0.00058	0.00101	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000579	0.00101	CcSEcCtD
Zuclopenthixol—Convulsion—Dexamethasone—multiple sclerosis	0.000578	0.00101	CcSEcCtD
Zuclopenthixol—Convulsion—Betamethasone—multiple sclerosis	0.000578	0.00101	CcSEcCtD
Zuclopenthixol—Hypertension—Dexamethasone—multiple sclerosis	0.000576	0.00101	CcSEcCtD
Zuclopenthixol—Hypertension—Betamethasone—multiple sclerosis	0.000576	0.00101	CcSEcCtD
Zuclopenthixol—Asthenia—Mitoxantrone—multiple sclerosis	0.00057	0.000999	CcSEcCtD
Zuclopenthixol—Myalgia—Dexamethasone—multiple sclerosis	0.000568	0.000994	CcSEcCtD
Zuclopenthixol—Myalgia—Betamethasone—multiple sclerosis	0.000568	0.000994	CcSEcCtD
Zuclopenthixol—Anxiety—Betamethasone—multiple sclerosis	0.000566	0.000991	CcSEcCtD
Zuclopenthixol—Anxiety—Dexamethasone—multiple sclerosis	0.000566	0.000991	CcSEcCtD
Zuclopenthixol—Discomfort—Dexamethasone—multiple sclerosis	0.000561	0.000982	CcSEcCtD
Zuclopenthixol—Discomfort—Betamethasone—multiple sclerosis	0.000561	0.000982	CcSEcCtD
Zuclopenthixol—Hypotension—Methylprednisolone—multiple sclerosis	0.000559	0.000979	CcSEcCtD
Zuclopenthixol—Pain—Prednisolone—multiple sclerosis	0.000558	0.000977	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000551	0.000964	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—multiple sclerosis	0.000547	0.000958	CcSEcCtD
Zuclopenthixol—Urethral disorder—Methotrexate—multiple sclerosis	0.000547	0.000957	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000546	0.000957	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000545	0.000955	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000544	0.000953	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000544	0.000953	CcSEcCtD
Zuclopenthixol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000544	0.000953	CcSEcCtD
Zuclopenthixol—Insomnia—Triamcinolone—multiple sclerosis	0.000542	0.00095	CcSEcCtD
Zuclopenthixol—Insomnia—Methylprednisolone—multiple sclerosis	0.000541	0.000948	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisone—multiple sclerosis	0.000539	0.000944	CcSEcCtD
Zuclopenthixol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000539	0.000943	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000537	0.000941	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000537	0.000941	CcSEcCtD
Zuclopenthixol—Visual impairment—Methotrexate—multiple sclerosis	0.000537	0.000941	CcSEcCtD
Zuclopenthixol—Shock—Betamethasone—multiple sclerosis	0.000535	0.000938	CcSEcCtD
Zuclopenthixol—Shock—Dexamethasone—multiple sclerosis	0.000535	0.000938	CcSEcCtD
Zuclopenthixol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000535	0.000936	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000534	0.000935	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000534	0.000935	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—multiple sclerosis	0.000534	0.000935	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000533	0.000933	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000533	0.000933	CcSEcCtD
Zuclopenthixol—Tachycardia—Dexamethasone—multiple sclerosis	0.000531	0.00093	CcSEcCtD
Zuclopenthixol—Tachycardia—Betamethasone—multiple sclerosis	0.000531	0.00093	CcSEcCtD
Zuclopenthixol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000528	0.000925	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000527	0.000923	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000526	0.000921	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000526	0.000921	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—multiple sclerosis	0.000524	0.000917	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—multiple sclerosis	0.000522	0.000914	CcSEcCtD
Zuclopenthixol—Eye disorder—Methotrexate—multiple sclerosis	0.000521	0.000912	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—multiple sclerosis	0.000521	0.000912	CcSEcCtD
Zuclopenthixol—Tinnitus—Methotrexate—multiple sclerosis	0.00052	0.00091	CcSEcCtD
Zuclopenthixol—Anorexia—Dexamethasone—multiple sclerosis	0.000519	0.000908	CcSEcCtD
Zuclopenthixol—Anorexia—Betamethasone—multiple sclerosis	0.000519	0.000908	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Methotrexate—multiple sclerosis	0.000517	0.000906	CcSEcCtD
Zuclopenthixol—Fatigue—Triamcinolone—multiple sclerosis	0.000517	0.000906	CcSEcCtD
Zuclopenthixol—Fatigue—Methylprednisolone—multiple sclerosis	0.000516	0.000904	CcSEcCtD
Zuclopenthixol—Pain—Triamcinolone—multiple sclerosis	0.000513	0.000898	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—multiple sclerosis	0.00051	0.000894	CcSEcCtD
Zuclopenthixol—Hypotension—Dexamethasone—multiple sclerosis	0.000509	0.000891	CcSEcCtD
Zuclopenthixol—Hypotension—Betamethasone—multiple sclerosis	0.000509	0.000891	CcSEcCtD
Zuclopenthixol—Angiopathy—Methotrexate—multiple sclerosis	0.000506	0.000886	CcSEcCtD
Zuclopenthixol—Vomiting—Mitoxantrone—multiple sclerosis	0.000505	0.000885	CcSEcCtD
Zuclopenthixol—Immune system disorder—Methotrexate—multiple sclerosis	0.000504	0.000882	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—multiple sclerosis	0.000503	0.000881	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—multiple sclerosis	0.000501	0.000878	CcSEcCtD
Zuclopenthixol—Rash—Mitoxantrone—multiple sclerosis	0.000501	0.000878	CcSEcCtD
Zuclopenthixol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000501	0.000877	CcSEcCtD
Zuclopenthixol—Headache—Mitoxantrone—multiple sclerosis	0.000498	0.000872	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000496	0.000868	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000496	0.000868	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—multiple sclerosis	0.000494	0.000866	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000494	0.000866	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000493	0.000864	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—multiple sclerosis	0.000493	0.000863	CcSEcCtD
Zuclopenthixol—Insomnia—Dexamethasone—multiple sclerosis	0.000492	0.000862	CcSEcCtD
Zuclopenthixol—Insomnia—Betamethasone—multiple sclerosis	0.000492	0.000862	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000491	0.00086	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000489	0.000857	CcSEcCtD
Zuclopenthixol—Paraesthesia—Betamethasone—multiple sclerosis	0.000489	0.000856	CcSEcCtD
Zuclopenthixol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000489	0.000856	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—multiple sclerosis	0.000488	0.000855	CcSEcCtD
Zuclopenthixol—Mental disorder—Methotrexate—multiple sclerosis	0.000488	0.000855	CcSEcCtD
Zuclopenthixol—Malnutrition—Methotrexate—multiple sclerosis	0.000485	0.00085	CcSEcCtD
Zuclopenthixol—Erythema—Methotrexate—multiple sclerosis	0.000485	0.00085	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000481	0.000842	CcSEcCtD
Zuclopenthixol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000479	0.000839	CcSEcCtD
Zuclopenthixol—Dyspepsia—Betamethasone—multiple sclerosis	0.000479	0.000839	CcSEcCtD
Zuclopenthixol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000474	0.00083	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000474	0.00083	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000473	0.000829	CcSEcCtD
Zuclopenthixol—Decreased appetite—Betamethasone—multiple sclerosis	0.000473	0.000829	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000473	0.000829	CcSEcCtD
Zuclopenthixol—Nausea—Mitoxantrone—multiple sclerosis	0.000472	0.000827	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00047	0.000823	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00047	0.000823	CcSEcCtD
Zuclopenthixol—Fatigue—Dexamethasone—multiple sclerosis	0.000469	0.000822	CcSEcCtD
Zuclopenthixol—Fatigue—Betamethasone—multiple sclerosis	0.000469	0.000822	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—multiple sclerosis	0.000466	0.000817	CcSEcCtD
Zuclopenthixol—Pain—Betamethasone—multiple sclerosis	0.000465	0.000815	CcSEcCtD
Zuclopenthixol—Pain—Dexamethasone—multiple sclerosis	0.000465	0.000815	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—multiple sclerosis	0.000465	0.000814	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—multiple sclerosis	0.000463	0.00081	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—multiple sclerosis	0.00046	0.000806	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—multiple sclerosis	0.000458	0.000802	CcSEcCtD
Zuclopenthixol—Vision blurred—Methotrexate—multiple sclerosis	0.000457	0.000801	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—multiple sclerosis	0.000452	0.000791	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00045	0.000789	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000448	0.000785	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000448	0.000785	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000445	0.000779	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000445	0.000779	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000442	0.000774	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000441	0.000772	CcSEcCtD
Zuclopenthixol—Malaise—Methotrexate—multiple sclerosis	0.000438	0.000766	CcSEcCtD
Zuclopenthixol—Vertigo—Methotrexate—multiple sclerosis	0.000436	0.000764	CcSEcCtD
Zuclopenthixol—Leukopenia—Methotrexate—multiple sclerosis	0.000434	0.000761	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000432	0.000756	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—multiple sclerosis	0.000431	0.000755	CcSEcCtD
Zuclopenthixol—Asthenia—Triamcinolone—multiple sclerosis	0.00043	0.000754	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dexamethasone—multiple sclerosis	0.00043	0.000753	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betamethasone—multiple sclerosis	0.00043	0.000753	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dexamethasone—multiple sclerosis	0.00043	0.000753	CcSEcCtD
Zuclopenthixol—Abdominal pain—Betamethasone—multiple sclerosis	0.00043	0.000753	CcSEcCtD
Zuclopenthixol—Asthenia—Methylprednisolone—multiple sclerosis	0.000429	0.000752	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—multiple sclerosis	0.000429	0.000751	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—multiple sclerosis	0.000426	0.000745	CcSEcCtD
Zuclopenthixol—Pruritus—Triamcinolone—multiple sclerosis	0.000424	0.000743	CcSEcCtD
Zuclopenthixol—Pruritus—Methylprednisolone—multiple sclerosis	0.000423	0.000741	CcSEcCtD
Zuclopenthixol—Convulsion—Methotrexate—multiple sclerosis	0.00042	0.000736	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—multiple sclerosis	0.000417	0.000731	CcSEcCtD
Zuclopenthixol—Myalgia—Methotrexate—multiple sclerosis	0.000413	0.000724	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—multiple sclerosis	0.000412	0.000722	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—multiple sclerosis	0.000411	0.00072	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—multiple sclerosis	0.000411	0.00072	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00041	0.000719	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000409	0.000717	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—multiple sclerosis	0.000409	0.000716	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—multiple sclerosis	0.000409	0.000716	CcSEcCtD
Zuclopenthixol—Discomfort—Methotrexate—multiple sclerosis	0.000408	0.000715	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—multiple sclerosis	0.000405	0.00071	CcSEcCtD
Zuclopenthixol—Dizziness—Triamcinolone—multiple sclerosis	0.000397	0.000695	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000396	0.000694	CcSEcCtD
Zuclopenthixol—Dizziness—Methylprednisolone—multiple sclerosis	0.000396	0.000693	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—multiple sclerosis	0.000391	0.000684	CcSEcCtD
Zuclopenthixol—Asthenia—Betamethasone—multiple sclerosis	0.00039	0.000684	CcSEcCtD
Zuclopenthixol—Asthenia—Dexamethasone—multiple sclerosis	0.00039	0.000684	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000388	0.00068	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000388	0.000679	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000388	0.000679	CcSEcCtD
Zuclopenthixol—Nausea—Prednisolone—multiple sclerosis	0.000387	0.000678	CcSEcCtD
Zuclopenthixol—Pruritus—Betamethasone—multiple sclerosis	0.000385	0.000674	CcSEcCtD
Zuclopenthixol—Pruritus—Dexamethasone—multiple sclerosis	0.000385	0.000674	CcSEcCtD
Zuclopenthixol—Skin disorder—Methotrexate—multiple sclerosis	0.000385	0.000674	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000383	0.000671	CcSEcCtD
Zuclopenthixol—Vomiting—Triamcinolone—multiple sclerosis	0.000381	0.000668	CcSEcCtD
Zuclopenthixol—Vomiting—Methylprednisolone—multiple sclerosis	0.000381	0.000666	CcSEcCtD
Zuclopenthixol—Rash—Triamcinolone—multiple sclerosis	0.000378	0.000662	CcSEcCtD
Zuclopenthixol—Dermatitis—Triamcinolone—multiple sclerosis	0.000378	0.000662	CcSEcCtD
Zuclopenthixol—Anorexia—Methotrexate—multiple sclerosis	0.000378	0.000661	CcSEcCtD
Zuclopenthixol—Rash—Methylprednisolone—multiple sclerosis	0.000377	0.000661	CcSEcCtD
Zuclopenthixol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000377	0.00066	CcSEcCtD
Zuclopenthixol—Headache—Triamcinolone—multiple sclerosis	0.000376	0.000658	CcSEcCtD
Zuclopenthixol—Headache—Methylprednisolone—multiple sclerosis	0.000375	0.000657	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—multiple sclerosis	0.000375	0.000656	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—multiple sclerosis	0.000375	0.000656	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000372	0.000652	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betamethasone—multiple sclerosis	0.000372	0.000652	CcSEcCtD
Zuclopenthixol—Hypotension—Methotrexate—multiple sclerosis	0.00037	0.000648	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000361	0.000632	CcSEcCtD
Zuclopenthixol—Dizziness—Betamethasone—multiple sclerosis	0.00036	0.00063	CcSEcCtD
Zuclopenthixol—Dizziness—Dexamethasone—multiple sclerosis	0.00036	0.00063	CcSEcCtD
Zuclopenthixol—Insomnia—Methotrexate—multiple sclerosis	0.000358	0.000627	CcSEcCtD
Zuclopenthixol—Nausea—Triamcinolone—multiple sclerosis	0.000356	0.000624	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methotrexate—multiple sclerosis	0.000356	0.000623	CcSEcCtD
Zuclopenthixol—Nausea—Methylprednisolone—multiple sclerosis	0.000355	0.000623	CcSEcCtD
Zuclopenthixol—Dyspnoea—Methotrexate—multiple sclerosis	0.000353	0.000618	CcSEcCtD
Zuclopenthixol—Somnolence—Methotrexate—multiple sclerosis	0.000352	0.000617	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—multiple sclerosis	0.000349	0.000612	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methotrexate—multiple sclerosis	0.000349	0.000611	CcSEcCtD
Zuclopenthixol—Vomiting—Dexamethasone—multiple sclerosis	0.000346	0.000606	CcSEcCtD
Zuclopenthixol—Vomiting—Betamethasone—multiple sclerosis	0.000346	0.000606	CcSEcCtD
Zuclopenthixol—Decreased appetite—Methotrexate—multiple sclerosis	0.000344	0.000603	CcSEcCtD
Zuclopenthixol—Rash—Dexamethasone—multiple sclerosis	0.000343	0.000601	CcSEcCtD
Zuclopenthixol—Rash—Betamethasone—multiple sclerosis	0.000343	0.000601	CcSEcCtD
Zuclopenthixol—Dermatitis—Betamethasone—multiple sclerosis	0.000343	0.0006	CcSEcCtD
Zuclopenthixol—Dermatitis—Dexamethasone—multiple sclerosis	0.000343	0.0006	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000342	0.000599	CcSEcCtD
Zuclopenthixol—Fatigue—Methotrexate—multiple sclerosis	0.000341	0.000598	CcSEcCtD
Zuclopenthixol—Headache—Betamethasone—multiple sclerosis	0.000341	0.000597	CcSEcCtD
Zuclopenthixol—Headache—Dexamethasone—multiple sclerosis	0.000341	0.000597	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—multiple sclerosis	0.00034	0.000596	CcSEcCtD
Zuclopenthixol—Pain—Methotrexate—multiple sclerosis	0.000339	0.000593	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—multiple sclerosis	0.000335	0.000587	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000326	0.000572	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—multiple sclerosis	0.000324	0.000568	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000324	0.000567	CcSEcCtD
Zuclopenthixol—Nausea—Dexamethasone—multiple sclerosis	0.000323	0.000566	CcSEcCtD
Zuclopenthixol—Nausea—Betamethasone—multiple sclerosis	0.000323	0.000566	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—multiple sclerosis	0.000313	0.000549	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methotrexate—multiple sclerosis	0.000313	0.000548	CcSEcCtD
Zuclopenthixol—Body temperature increased—Methotrexate—multiple sclerosis	0.000313	0.000548	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—multiple sclerosis	0.000301	0.000528	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—multiple sclerosis	0.000299	0.000523	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—multiple sclerosis	0.000299	0.000523	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—multiple sclerosis	0.000297	0.00052	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000292	0.000511	CcSEcCtD
Zuclopenthixol—Asthenia—Methotrexate—multiple sclerosis	0.000284	0.000498	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—multiple sclerosis	0.000282	0.000493	CcSEcCtD
Zuclopenthixol—Pruritus—Methotrexate—multiple sclerosis	0.00028	0.000491	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methotrexate—multiple sclerosis	0.000271	0.000475	CcSEcCtD
Zuclopenthixol—Dizziness—Methotrexate—multiple sclerosis	0.000262	0.000459	CcSEcCtD
Zuclopenthixol—Vomiting—Methotrexate—multiple sclerosis	0.000252	0.000441	CcSEcCtD
Zuclopenthixol—Rash—Methotrexate—multiple sclerosis	0.00025	0.000437	CcSEcCtD
Zuclopenthixol—Dermatitis—Methotrexate—multiple sclerosis	0.00025	0.000437	CcSEcCtD
Zuclopenthixol—Headache—Methotrexate—multiple sclerosis	0.000248	0.000435	CcSEcCtD
Zuclopenthixol—Nausea—Methotrexate—multiple sclerosis	0.000235	0.000412	CcSEcCtD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	6.19e-05	0.000353	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	6.1e-05	0.000347	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—POMC—multiple sclerosis	6.04e-05	0.000344	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CD86—multiple sclerosis	5.98e-05	0.000341	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL3—multiple sclerosis	5.91e-05	0.000337	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CCL2—multiple sclerosis	5.91e-05	0.000337	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL5—multiple sclerosis	5.89e-05	0.000335	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL10—multiple sclerosis	5.89e-05	0.000335	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	5.83e-05	0.000332	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	5.82e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL3—multiple sclerosis	5.81e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	5.8e-05	0.00033	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	5.75e-05	0.000328	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	5.75e-05	0.000328	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	5.74e-05	0.000327	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	5.73e-05	0.000326	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL2—multiple sclerosis	5.71e-05	0.000325	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	5.7e-05	0.000325	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	5.69e-05	0.000324	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.67e-05	0.000323	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	5.66e-05	0.000322	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CD80—multiple sclerosis	5.65e-05	0.000322	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	5.64e-05	0.000322	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	5.62e-05	0.00032	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PGR—multiple sclerosis	5.61e-05	0.000319	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	5.6e-05	0.000319	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	5.59e-05	0.000318	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—BCHE—multiple sclerosis	5.58e-05	0.000318	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	5.54e-05	0.000316	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PGR—multiple sclerosis	5.52e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PGR—multiple sclerosis	5.5e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	5.5e-05	0.000313	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	5.48e-05	0.000312	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SPP1—multiple sclerosis	5.45e-05	0.00031	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CD28—multiple sclerosis	5.45e-05	0.00031	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	5.41e-05	0.000308	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	5.4e-05	0.000308	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	5.4e-05	0.000307	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—POMC—multiple sclerosis	5.37e-05	0.000306	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TYK2—multiple sclerosis	5.36e-05	0.000306	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CD28—multiple sclerosis	5.36e-05	0.000305	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR2—multiple sclerosis	5.35e-05	0.000305	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CD28—multiple sclerosis	5.35e-05	0.000305	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCR5—multiple sclerosis	5.3e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	5.3e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	5.29e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	5.26e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL2—multiple sclerosis	5.26e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CCL2—multiple sclerosis	5.25e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR2—multiple sclerosis	5.25e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	5.25e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2RA—multiple sclerosis	5.23e-05	0.000298	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	5.22e-05	0.000297	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL2—multiple sclerosis	5.19e-05	0.000295	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	5.15e-05	0.000294	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	5.15e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CD86—multiple sclerosis	5.15e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—MAPK1—multiple sclerosis	5.14e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	5.1e-05	0.00029	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL5—multiple sclerosis	5.07e-05	0.000289	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	5.02e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	5.02e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	4.94e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CNR1—multiple sclerosis	4.94e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	4.93e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	4.92e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2—multiple sclerosis	4.92e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	4.87e-05	0.000278	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	4.86e-05	0.000277	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CNR1—multiple sclerosis	4.85e-05	0.000276	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	4.84e-05	0.000276	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—APOE—multiple sclerosis	4.82e-05	0.000275	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	4.79e-05	0.000273	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TYK2—multiple sclerosis	4.77e-05	0.000272	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	4.75e-05	0.000271	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SPP1—multiple sclerosis	4.69e-05	0.000267	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCR5—multiple sclerosis	4.56e-05	0.00026	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—POMC—multiple sclerosis	4.56e-05	0.00026	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2RA—multiple sclerosis	4.5e-05	0.000256	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	4.49e-05	0.000256	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	4.49e-05	0.000256	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—POMC—multiple sclerosis	4.48e-05	0.000255	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—multiple sclerosis	4.46e-05	0.000254	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	4.46e-05	0.000254	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	4.44e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	4.42e-05	0.000252	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	4.39e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	4.39e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	4.38e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	4.37e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	4.36e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CD80—multiple sclerosis	4.36e-05	0.000248	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	4.3e-05	0.000245	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	4.28e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APOE—multiple sclerosis	4.15e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—multiple sclerosis	4.14e-05	0.000236	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	4.1e-05	0.000234	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	4.08e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL2—multiple sclerosis	4.05e-05	0.000231	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	4.05e-05	0.000231	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	4.02e-05	0.000229	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	3.99e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	3.99e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	3.98e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	3.98e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—multiple sclerosis	3.97e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	3.97e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—multiple sclerosis	3.95e-05	0.000225	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	3.9e-05	0.000222	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CD86—multiple sclerosis	3.89e-05	0.000221	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL5—multiple sclerosis	3.82e-05	0.000218	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CD86—multiple sclerosis	3.82e-05	0.000218	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CD86—multiple sclerosis	3.81e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	3.76e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MMP9—multiple sclerosis	3.76e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL5—multiple sclerosis	3.76e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CD80—multiple sclerosis	3.75e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	3.74e-05	0.000213	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	3.71e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	3.69e-05	0.00021	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TYK2—multiple sclerosis	3.68e-05	0.00021	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	3.65e-05	0.000208	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	3.64e-05	0.000208	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—BCHE—multiple sclerosis	3.64e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	3.63e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	3.58e-05	0.000204	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—multiple sclerosis	3.57e-05	0.000203	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPP1—multiple sclerosis	3.54e-05	0.000202	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL2—multiple sclerosis	3.49e-05	0.000199	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	3.49e-05	0.000199	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	3.48e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPP1—multiple sclerosis	3.48e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR5—multiple sclerosis	3.45e-05	0.000196	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	3.42e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	3.41e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	3.41e-05	0.000194	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	3.4e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	3.39e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR5—multiple sclerosis	3.38e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—multiple sclerosis	3.37e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APOE—multiple sclerosis	3.36e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	3.34e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—STAT3—multiple sclerosis	3.34e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	3.33e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	3.32e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	3.32e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	3.32e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—multiple sclerosis	3.31e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	3.27e-05	0.000186	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	3.25e-05	0.000185	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	3.17e-05	0.000181	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TYK2—multiple sclerosis	3.17e-05	0.000181	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOE—multiple sclerosis	3.14e-05	0.000179	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MYC—multiple sclerosis	3.1e-05	0.000177	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—multiple sclerosis	3.1e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	3.08e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOE—multiple sclerosis	3.08e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOE—multiple sclerosis	3.08e-05	0.000175	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—multiple sclerosis	3.06e-05	0.000175	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—multiple sclerosis	3.05e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	3.04e-05	0.000173	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MAPK1—multiple sclerosis	3.04e-05	0.000173	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	3.02e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	3.02e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—multiple sclerosis	2.9e-05	0.000165	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—multiple sclerosis	2.88e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CD80—multiple sclerosis	2.83e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	2.81e-05	0.00016	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CD80—multiple sclerosis	2.79e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CD80—multiple sclerosis	2.78e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	2.73e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—multiple sclerosis	2.69e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—multiple sclerosis	2.65e-05	0.000151	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—multiple sclerosis	2.64e-05	0.000151	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—multiple sclerosis	2.64e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—multiple sclerosis	2.64e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—multiple sclerosis	2.63e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—multiple sclerosis	2.62e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	2.59e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	2.59e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—multiple sclerosis	2.59e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	2.58e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—STAT3—multiple sclerosis	2.58e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	2.54e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	2.54e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	2.54e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	2.53e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—multiple sclerosis	2.5e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.48e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	2.41e-05	0.000137	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MYC—multiple sclerosis	2.4e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TYK2—multiple sclerosis	2.39e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	2.39e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	2.36e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	2.35e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TYK2—multiple sclerosis	2.35e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	2.34e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—multiple sclerosis	2.33e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	2.31e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	2.31e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—STAT3—multiple sclerosis	2.22e-05	0.000126	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—multiple sclerosis	2.19e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	2.14e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MYC—multiple sclerosis	2.06e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	2.06e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	2.02e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.99e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.98e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.96e-05	0.000112	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.95e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.95e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.95e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.92e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.91e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.88e-05	0.000107	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—multiple sclerosis	1.88e-05	0.000107	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.85e-05	0.000106	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—multiple sclerosis	1.85e-05	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.82e-05	0.000103	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—multiple sclerosis	1.8e-05	0.000103	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.78e-05	0.000102	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.77e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—multiple sclerosis	1.71e-05	9.76e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.69e-05	9.61e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.68e-05	9.54e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	1.65e-05	9.39e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT3—multiple sclerosis	1.64e-05	9.37e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.61e-05	9.2e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.56e-05	8.87e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-05	8.85e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—multiple sclerosis	1.55e-05	8.83e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MYC—multiple sclerosis	1.53e-05	8.73e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MYC—multiple sclerosis	1.53e-05	8.71e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	1.53e-05	8.71e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	1.52e-05	8.69e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-05	8.68e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.5e-05	8.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.5e-05	8.54e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	1.5e-05	8.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.5e-05	8.52e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	1.5e-05	8.52e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.47e-05	8.36e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.39e-05	7.94e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.39e-05	7.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1.36e-05	7.77e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—multiple sclerosis	1.17e-05	6.67e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—multiple sclerosis	1.15e-05	6.56e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—multiple sclerosis	1.15e-05	6.55e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.13e-05	6.42e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1.05e-05	5.97e-05	CbGpPWpGaD
